The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers
Open accessAbstract
PURPOSE: Uterine corpus cancer incidence rates have been projected to increase, a prediction often attributed to the obesity epidemic. However, correct estimation of these rates requires accounting for hysterectomy prevalence, which varies by race, ethnicity, and region. Here, we evaluated recent trends in hysterectomy-corrected rates by race and ethnicity and histologic subtype and estimated differences in relative survival by race and ethnicity, subtype, and stage. METHODS: We estimated hysterectomy prevalence from the Behavioral Risk Factor Surveillance System. Hysterectomy-corrected age-standardized uterine corpus cancer incidence rates from 2000 to 2015 were calculated from the SEER 18 registries. Incidence rates and trends were estimated separately by race and ethnicity, region, and histologic subtype. Five-year relative survival rates were estimated by race and ethnicity, histologic subtype, and stage. RESULTS: Hysterectomy-corrected incidence rates of uterine corpus cancer were similar among non-Hispanic whites and blacks and lower among Hispanics and Asians/Pacific Islanders. Endometrioid carcinoma rates were highest in non-Hispanic whites, whereas nonendometrioid carcinoma and sarcoma rates were highest in non-Hispanic blacks. Hysterectomy-corrected uterine corpus cancer incidence increased among non-Hispanic whites from 2003 to 2015 and among non-Hispanic blacks, Hispanics, and Asians/Pacific Islanders from 2000 to 2015. Overall incidence rates among non-Hispanic blacks surpassed those of non-Hispanic whites in 2007. Endometrioid carcinoma rates rose among non-Hispanic blacks, Hispanics, and Asians/Pacific Islanders but were stable among non-Hispanic whites; however, nonendometrioid carcinoma rates rose significantly among all women. Non-Hispanic blacks had the lowest survival rates, irrespective of stage at diagnosis or histologic subtype. CONCLUSION: Among all women, rates of nonendometrioid subtypes have been rising rapidly. Our analysis shows profound racial differences and disparities indicated by higher rates of nonendometrioid subtypes and poorer survival among non-Hispanic black women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.
Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2017) · PubMed · Cited by 3,884
Prevalence of the metabolic syndrome in the United States, 2003-2012
Aguilar, M., Bhuket, T., Torres, S., Liu, B., & Wong, R. J. (2015) · JAMA · doi:10.1001/jama.2015.4260 · Cited by 1,267
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y.-B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2596 · Cited by 827
Self-citationInternational patterns and trends in endometrial cancer incidence, 1978-2013.
Lortet-Tieulent, J., Ferlay, J., Bray, F., & Jemal, A. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx214 · Cited by 760
Geiss, L. S., Wang, J., Cheng, Y. J., Thompson, T. J., Barker, L., Li, Y., Albright, A. L., & Gregg, E. W. (2014) · JAMA · doi:10.1001/jama.2014.11494 · Cited by 672
Pierannunzi, C., Hu, S. S., & Balluz, L. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-49 · Cited by 536
Trends in the Prevalence of Type 2 Diabetes in Asians Versus Whites
Lee, J. W. R., Brancati, F. L., & Yeh, H.-C. (2011) · Diabetes Care · doi:10.2337/dc10-0746 · Cited by 305
The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women
Cote, M. L., Ruterbusch, J. J., Olson, S. H., Lu, K., & Ali-Fehmi, R. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0316 · Cited by 272
Uterine Cancer Incidence and Mortality — United States, 1999–2016
Henley, S. J., Miller, J. W., Dowling, N. F., Benard, V. B., & Richardson, L. C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6748a1 · Cited by 246
USA endometrial cancer projections to 2030: should we be concerned?
Sheikh, M. A., Althouse, A. D., Freese, K. E., Soisson, S., Edwards, R. P., Welburn, S., Sukumvanich, P., Comerci, J., Kelley, J., LaPorte, R. E., et al. (2014) · Future Oncology · doi:10.2217/fon.14.192 · Cited by 236
Sherman, M. E., & Devesa, S. S. (2003) · Cancer · doi:10.1002/cncr.11484 · Cited by 227
Self-citationHosh, M., Antar, S., Nazzal, A., Warda, M., Gibreel, A., & Refky, B. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000720 · Cited by 219
Cardiovascular Risk Factors among Asian Americans: Results from a National Health Survey
Ye, J., Rust, G., Baltrus, P., & Daniels, E. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.03.022 · Cited by 195
Long, B., Liu, F. W., & Bristow, R. E. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.05.020 · Cited by 174
Bokhman Redux: Endometrial cancer “types” in the 21st century
Suarez, A. A., Felix, A. S., & Cohn, D. E. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.12.010 · Cited by 163
Graphical Presentation of Trends in Rates
Devesa, S. S., Donaldson, J., & Fears, T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/141.4.300 · Cited by 159
Self-citationRandall, T. C., & Armstrong, K. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.218 · Cited by 112
Jamison, P. M., Noone, A.-M., Ries, L. A. G., Lee, N. C., & Edwards, B. K. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0996 · Cited by 101
Recent changes in endometrial cancer trends among menopausal-age US women.
Wartko, P., Sherman, M. E., Yang, H. P., Felix, A. S., Brinton, L. A., & Trabert, B. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.03.008 · Cited by 98
Cancer Progress and Priorities: Uterine Cancer
Felix, A. S., & Brinton, L. A. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0264 · Cited by 98
Polite, B. N., Adams-Campbell, L. L., Brawley, O. W., Bickell, N. A., Carethers, J. M., Flowers, C. R., Foti, M., Gomez, S. L., Griggs, J. J., Lathan, C. S., et al. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21404 · Cited by 85
Bregar, A. J., Rauh‐Hain, J. A., Spencer, R. J., Clemmer, J. T., Schorge, J. O., Rice, L. W., & Carmen, M. G. D. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.01.024 · Cited by 84
The Impact of Race and Comorbidity on Survival in Endometrial Cancer
Olson, S. H., Atoria, C. L., Coté, M. L., Cook, L. S., Rastogi, R. M., Soslow, R. A., Brown, C. L., & Elkin, E. B. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0735 · Cited by 82
Polite, B. N., Adams-Campbell, L. L., Brawley, O. W., Bickell, N. A., Carethers, J. M., Flowers, C. R., Foti, M., Gomez, S. L., Griggs, J. J., Lathan, C. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.6546 · Cited by 82
Mariotto, A., Zou, Z.-H., Johnson, C. J., Scoppa, S., Weir, H., & Huang, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201034 · Cited by 63
Impact of Hysterectomy on Endometrial Carcinoma Rates in the United States
Sherman, M. E., Carreon, J. D., Lacey, J. V., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji378 · Cited by 61
Racial disparities in outcomes for high‐grade uterine cancer: A California cancer registry study
Baskovic, M., Lichtensztajn, D. Y., Nguyen, T. T., Karam, A., & English, D. P.-G. (2018) · Cancer Medicine · doi:10.1002/cam4.1742 · Cited by 57
Siegel, R. L., Devesa, S. S., Cokkinides, V. E., Ma, J., & Jemal, A. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0991 · Cited by 46
Self-citationComorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites
Cook, L. S., Nelson, H. E., Cockburn, M., Olson, S. H., Muller, C. Y., & Wiggins, C. L. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0090-z · Cited by 44
Temkin, S. M., Kohn, E. C., Penberthy, L. T., Cronin, K. A., Rubinsak, L. A., Dickie, L. A., Minasian, L. M., & Noone, A. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1018-z · Cited by 32
Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women
Rodriguez, A. M., Schmeler, K. M., & Kuo, Y. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.10.021 · Cited by 30
Mahdi, H., Hou, H., Kowk, L.-L., Kebria, M. M., & Michener, C. M. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.03.562 · Cited by 26
Faber, M. T., Frederiksen, K., Jensen, A., Aarslev, P. B., & Kjær, S. K. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.05.015 · Cited by 23
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Cancer treatment and survivorship statistics, 2022
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21731 · Cited by 3,597
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R., Shahin, M. S., Cantuaria, G. H., Girda, E., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2302312 · Cited by 758
Lu, K. H., & Broaddus, R. R. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1514010 · Cited by 663
Metadata
- Authors
- Clarke, M. A., Devesa, S. S., Harvey, S. V., & Wentzensen, N.
- Venue
- Journal of Clinical Oncology
- Published
- 2019-08-01
- Volume
- 37
- Issue
- 22
- Pages
- 1895-1908
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2945254664
- Cited by
- 299
- References
- 36
- FWCI
- 26.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.